GAMASTAN Solution for injection Ref.[10819] Active ingredients: Human normal immunoglobulin G

Source: FDA, National Drug Code (US)  Revision Year: 2020 

12.1. Mechanism of Action

The polyclonal antibody in GAMASTAN is a passive immunizing agent to neutralize viruses, such as hepatitis A and measles viruses, to prevent or ameliorate disease.

12.2. Pharmacodynamics

The prophylactic value of GAMASTAN is greatest when given before or soon after exposure.

12.3. Pharmacokinetics

Peak levels of immunoglobulin G are obtained approximately two days after intramuscular injection of GAMASTAN.(16) The half-life of IgG in the circulation of individuals with normal IgG levels is 23 days.(17)

In a clinical study, 12 healthy human subjects received a 20 IU/kg intramuscular dose of HYPERRAB, (Rabies Immune Globulin (Human)), made using the same manufacturing process as GAMASTAN. Detectable passive rabies neutralizing antibody was present by 24 hours and persisted through the 21 day follow-up evaluation period. The figure below shows the mean levels of rabies virus antibodies in IU/mL across the 21 day evaluation period and indicates that the titer remains stable during this period.

Mean (Standard Deviation) Rabies Virus Antibody Levels (IU/mL) versus Time following a Single 20 IU/kg Dose of HYPERRAB (300 IU/mL) by Intramuscular Injection:

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.